Evaluation of the Release of Monomers From Composite Bonding Resins in Orthodontics
MONORTHO
1 other identifier
observational
41
1 country
1
Brief Summary
In recent decades, the field of public health has become increasingly interested in endocrine disruptors, and their effects on humans. Indeed, various scientific studies have highlighted an evolution in the frequency of pathologies due to these substances, affecting in particular the reproductive organs. Many concerns are expressed about the impact of these substances, present in the environment or in consumer products, on the hormonal system. Effects have been observed in animals in experimental studies, but the question of extrapolating these results to humans arises, especially for exposures at low doses. In orthodontics, the composite is the material of choice mainly for bonding fasteners, then bonding a compression wire. These composite materials contain many monomers. The polemics launched on Bisphenol A and the questions of our patients on the nature and toxicity of dental products oblige us to reflect on their harmfulness after their placement in the oral cavity. Many questions arise today about dental composites and their participation in the release of endocrine disruptors. Indeed, Bisphenol A is used in the manufacturing process of the monomers of orthodontic composites, as precursors of Bis-GMA and Bis-DMA. The objective of this study is to search for the presence of BPA, TEGDMA, BisGMA, BisDMA and UDMA monomers, and to carry out the samples and their analysis at different clinical times (at T0, after the removal of orthodontic attachments, after the placement of the compression, one hour later, one week later, one month later and 6 months later) and the comparison of this quantification to that without orthodontic restraint. Studies have been performed in vitro, but very little in vivo. In addition, these studies are only carried out on release at the time of installation, but few are interested in the continuation of the phenomenon over time and the deterioration of the composite. Although the short-term toxicity of BPA is low, its dangerousness lies in its potential endocrine disrupting effect and which can induce long-term chronic toxicity. Compounds such as TEGDMA, BisGMA, BisDMA and UDMA differ greatly in their volatility due to their different chemical structures as well as in their stability in saliva; Many methods have been developed to study each monomer individually or to study them simultaneously using different analytical techniques to determine their presence and to quantify them after their release from dental products. The analysis of the samples is carried out by liquid chromatography (HPLC).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 3, 2020
CompletedFirst Submitted
Initial submission to the registry
June 17, 2020
CompletedFirst Posted
Study publicly available on registry
July 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 16, 2020
CompletedNovember 21, 2023
November 1, 2023
5 months
June 17, 2020
November 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changement of quantity of the Bisphenol A
The main objective of this research is the quantification of the Bisphenol A monomer released during the placement of a mandibular orthodontic compression in order to raise awareness among professionals or without orthodontic restraint..
before any medical procedure, and regularly after the medical procedure
Secondary Outcomes (2)
Changement of quantity of the release of TEGDMA monomers; UDMA; BisGMA and BisDMA
before any medical procedure, and regularly after the medical procedure
Changement of those quantities in patients with mandibular orthodontic restraints with patients without restraints
before any medical procedure, and regularly after the medical procedure
Study Arms (1)
Patient of the orthodontic consultation
Interventions
The salivary samples will be collected at 5 defined times
Eligibility Criteria
Patient of the orthodontic consultation consultant in the dentistry department of the Pitié Salpêtrière hospital,
You may qualify if:
- Patient of the orthodontic consultation consultant in the dentistry department of the Pitié Salpêtrière hospital,
- Information and collection of the non-opposition of the adult patient or representatives of the parental authority for minors
- Good dental hygiene at the discretion of the investigator
- Patient agreeing to be followed for 6 months
- Good written and oral comprehension of the French language
- case-specific:
- Age between 10 and 70 years inclusive,
- Patients undergoing orthodontic treatment (multi-attachment device) with planned debagging and requiring compression with bonded mandibular wire from canine to canine, and maxillary groove
- Specific to witnesses:
- Age between 18 and 70 inclusive
- Patients undergoing orthodontic treatment (multi-attachment appliance) with planned debridement without the need for a retainer
You may not qualify if:
- Under tutorship or curatorship
- Opposition of the minor patient
- Gingival inflammation
- Patients requiring maxillary bonded restraint
- Composite restoration in the mouth
- Carious lesions
- Smokers
- Patients with chronic pathologies and / or under medication
- Chronic exposure to Bisphenol A.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service Odontology, Hôpital Pitié-Salpêtrière
Paris, Île-de-France Region, 75013, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2020
First Posted
July 7, 2020
Study Start
June 3, 2020
Primary Completion
October 30, 2020
Study Completion
December 16, 2020
Last Updated
November 21, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share